malignancy

Hypercalcemia Malignancy Factor (1-34), human is a polypeptide molecule with the sequence AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA.

SOR-C13 TFA, a truncated carboxy-terminal peptide, serves as a potent TRPV6 antagonist, demonstrating high affinity with an IC 50 value of 14 nM. TRPV6, a non-voltage-gated calcium channel linked to malignancy and poor prognosis in breast cancer, is effectively targeted by SOR-C13 TFA, indicating its anticancer activity [1].

Human PTHrP-(1-36) is a secreted parathyroid hormone-related protein with anticalciuric effects, promoting beta cell function and proliferation, and is used in research on humoral hypercalcemia of malignancy (HHM) and hyperparathyroidism [1] [3].

Human PTHrP-(1-34)NH2, also known as PTH-Related Protein (1-34) amide for human, mouse, and rat, is the N-terminal fragment of PTHrP. This peptide induces hypercalcemia and is utilized in the study of humoral hypercalcemia of malignancy [1].